Xu Zhenyu 4

What Happened Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA (SOPH), sold 608 shares in an open‑market transaction on April 20, 2026. The weighted average sale price was $5.21 per share, for total proceeds of approximately $3,165. This was a sale (not a purchase or option exercise).

Key Details

• Transaction date: April 20, 2026; Form 4 filed April 21, 2026 (timely).
• Transaction type/code: Sale (S).
• Price: weighted average $5.21; actual sale prices ranged from $5.10 to $5.29 (footnote F2).
• Total proceeds: ~$3,165.
• Shares owned after transaction: Not disclosed in this filing.
• Footnotes: F1 states the shares were sold to satisfy tax withholding from RSU vesting on April 18, 2026 and were sold under a pre‑established Rule 10b5‑1(c) plan (non‑discretionary). F2 notes the weighted average price and offers a breakdown of per‑price quantities upon request.

Context The sale was executed to cover tax withholding tied to restricted stock unit vesting and was made pursuant to a standing 10b5‑1 plan, which the filer says removes discretion from the timing of the trades. Such tax‑withholding sales are common and do not, by themselves, indicate the insider's view on the company's prospects.